Your browser doesn't support javascript.
loading
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Kwon, Daniel H; Chou, Jonathan; Yip, Steven M; Reimers, Melissa A; Zhang, Li; Wright, Francis; Dhawan, Mallika S; Borno, Hala T; Desai, Arpita; Aggarwal, Rahul R; Wyatt, Alexander W; Small, Eric J; Alva, Ajjai S; Chi, Kim N; Feng, Felix Y; Koshkin, Vadim S.
Afiliação
  • Kwon DH; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Chou J; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Yip SM; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
  • Reimers MA; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri.
  • Zhang L; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Wright F; Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, California.
  • Dhawan MS; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Borno HT; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Desai A; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Aggarwal RR; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Wyatt AW; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Small EJ; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Alva AS; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Chi KN; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Feng FY; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Koshkin VS; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
Cancer ; 127(12): 1965-1973, 2021 06 15.
Article em En | MEDLINE | ID: mdl-33690902
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article